Activity and Safety of Tegafur, Gimeracil, and Oteracil Potassium for Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis

In clinical practice, tegafur, gimeracil, and oteracil potassium (S-1) therapy is commonly administered to treat nasopharyngeal carcinoma (NPC). However, its efficacy and safety remain controversial in both randomized controlled trials (RCTs) and non-RCTs. We aimed to evaluate the efficacy and safet...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ximing, Tian, Xiumei, Wei, Yuezi, Deng, Hao, Ma, Lichun, Chen, Ziyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009729/
https://www.ncbi.nlm.nih.gov/pubmed/33859690
http://dx.doi.org/10.1155/2021/6690275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009729/
https://www.ncbi.nlm.nih.gov/pubmed/33859690
http://dx.doi.org/10.1155/2021/6690275

Ejemplares similares